MetaCap

CNS Pharmaceuticals Stock Forecast

NASDAQ: CNSPHealth CareBiotechnology: Pharmaceutical PreparationsUSD

5.35-0.08 (-1.47%)

At close: Oct 8, 4:00 PM ET · Delayed 15 min

CNSP analyst consensus

Consensus

none

Avg. price target

$10.00+86.92%

Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.

What analysts say

The average 12-month price target is $10.00, with a high estimate of $10.00 and a low estimate of $10.00. The average target implies upside of 86.9% from the current price of $5.35. The spread between the highest and lowest targets is 0.0%, a relatively narrow range.

Price targets and ratings are the opinions of third-party analysts, not MetaCap. They are frequently revised and have a mixed track record, so treat them as one input among many for CNSP.

Summary generated from market data by MetaCap's automated system. Methodology

Price target scenarios

Price targets versus the current price
TargetPricevs. current
Low target$10.00+86.92%
Average target$10.00+86.92%
High target$10.00+86.92%

How analysts view CNS Pharmaceuticals's peers

Peer analyst targets
CompanyConsensusPriceAvg. targetImplied move
AZTRbuy0.132$0.67+407.58%
FBLGnone1.11$12.50+1026.13%
LGVNnone2.37$61.25+2484.39%
SNGXnone0.3466$1.38+298.15%

Related